Sandoz Rolls Out Natalizumab Biosimilar In Germany

Tyruko Version Of Natalizumab Will Rival Biogen’s Tysabri In A Major EU Market

 
• By David Wallace
  
German flag in paint stripes
Sandoz is launching natalizumab in Germany • Source: Shutterstock

More from Products

More from Generics Bulletin